Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Qlucore, Nebion Collaborate

Published: Friday, February 07, 2014
Last Updated: Friday, February 07, 2014
Bookmark and Share
Partnership aims to address complementary use cases.

The start of 2014 will see Qlucore and Nebion AG working together to promote their two products Qlucore Omics Explorer and Genevestigator. 

Qlucore Omics Explorer is a next-generation bioinformatics software program which is extremely fast and allows the user to explore and analyse high-dimensional data sets interactively and in real time. Qlucore Omics Explorer has proved to be hugely beneficial to researchers in the life science and biotech industries when it comes to analysing big data.

Nebion creates innovative systems to extract high value information from the world's genomic data for biotechnology and personalized medicine. Its Genevestigator is a high-performance Web platform which deeply integrates expression data and curated sample annotations. This allows systematic screening of the database for genes that have unique expression properties and validation of target and biomarker genes by checking how they respond to thousands of experimental conditions.

"Nebion complements the Qlucore product offering perfectly by enabling a web based systematic screening of genes across many thousand experiments, so it makes perfect sense to work together to provide a broader solution to our clients. We're excited to be jointly promoting our complementary solutions to help researchers get better results, quickly," says Carl-Johan Ivarsson, CEO Qlucore.

Speaking on the new relationship between the two companies, Dr Philip Zimmermann, CEO Nebion commented, "I got to know Qlucore Omics Explorer a few years ago and I have become convinced that it's one of the best tools to find patterns in data and for biomarker discovery. It is very user-friendly but at the same time statistically robust."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Research Aims to Stop ‘Blood Doping' During Cycling and Other Competitive Sports
As cyclists take to the roads of Surrey, England, the subject of blood doping raises its head once again.
Thursday, August 01, 2013
Visualising Complex Data Results from 100,000 Cancer Patients
For decades, biomedical scientists have tried to develop a diagnostic tool for the early stages of cancer.
Wednesday, December 12, 2012
New Biomarkers Could Offer Vital Clues for Cancer Research
European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore.
Friday, May 04, 2012
New Research Techniques Could Help to Eliminate the Need for Animal Testing
Carl-Johan Ivarsson, Qlucore, comments on the reducing necessity for animal models in today’s drug development industry, as research moves more towards in vitro analysis.
Monday, March 19, 2012
Scientific News
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Milestone Single-Biomolecule Imaging Technique May Advance Drug Design
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography for imaging biomolecules at a single particle level; a milestone in structural biology and a potential new tool for drug design.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos